06/13/22 8:05 AMNasdaq : GH Guardant Health Completes Purchase of Guardant Health AMEA Joint VentureGuardant Health, Inc., a leading precision oncology company, today announced it has purchased the remaining shares of Guardant Health AMEA, Inc., held by SoftBank and its affiliates, giving the company full control over operations throughout the Asia, Middle East and Africa region. More than half of the world’ s estimated new cancer cases come from Asia, Middle...RHEA-AIneutral
05/26/22 4:05 PMNasdaq : GH conferencesGuardant Health to Participate in Upcoming June Investor ConferencesGuardant Health, Inc., a leading precision oncology company, today announced the company will be participating in the following investor conferences. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics. The Guardant Health oncology...RHEA-AIneutral
05/25/22 3:01 AMNasdaq : GH First Guardant Health Liquid Biopsy Testing Service in Europe Now Operational at Vall d’Hebron Institute of OncologyGuardant Health, Inc., a leading precision oncology company, and the Vall d’ Hebron Institute of Oncology, one of Europe’ s leading cancer research organizations, today announced that the first blood-based cancer testing services in Europe based on Guardant Health’ s industry-leading digital sequencing platform are now...RHEA-AIvery positive
05/23/22 8:05 AMNasdaq : GH conferencesGuardant Health to Present New Data from its Broad Portfolio of Blood Tests at 2022 American Society of Clinical Oncology (ASCO) Annual MeetingGuardant Health, Inc., a leading precision oncology company, announced today it will present new data at the 2022 American Society of Clinical Oncology Annual Meeting from June 3-7 in Chicago. Among the 19 abstracts are oral presentations highlighting the use of real-world data to identify resistance to early treatment in advanced breast cancer and the use...RHEA-AIneutral
05/21/22 3:01 AMNasdaq : GH Guardant Health Presents New Data Showing Blood Test Accuracy in Detecting Colorectal Cancer in First-of-its Kind Prospective Study at Digestive Disease Week 2022Guardant Health, Inc., a leading precision oncology company, today announced data showing its blood-based multimodal test achieved clinically significant thresholds of sensitivity and specificity in detecting colorectal cancer. Offering eligible individuals a blood-based test could help overcome many barriers associated with currently available...RHEA-AIneutral
05/05/22 4:05 PMNasdaq : GH earningsGuardant Health Reports First Quarter 2022 Financial ResultsGuardant Health, Inc., a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics, today reported financial results for the quarter ended March 31, 2022. Revenue of $96.1 million for the first quarter of 2022, an increase of 22% over the corresponding period of...RHEA-AIneutral
05/05/22 8:30 AMNYSE, Nasdaq : CPNG, GH, TXG managementFanatics Announces Appointment of Lydia Jett and Jonathan Mildenhall to Board of DirectorsFanatics, a leading global digital sports platform, today announced the appointment of preeminent fintech, e-commerce and marketing executives Lydia Jett and Jonathan Mildenhall to its board of directors. Lydia, the first female to hold the title of Managing Partner within SoftBank’ s Vision Fund, has nearly twenty years of experience investing in and...RHEA-AIpositive
05/02/22 8:05 AMNasdaq : GH Guardant Health Announces Shield™ Blood Test Available in US to Detect Early Signs of Colorectal Cancer in Average-Risk AdultsGuardant Health, Inc., a leading precision oncology company, today announced the availability of Shield™, the company’ s first blood-based test for the detection of early-stage colorectal cancer. Colorectal cancer is the second-leading cause of cancer-related deaths in the U.S. 1 Today, one in three adults have not completed the recommended CRC screening even...RHEA-AInegative
04/28/22 8:05 AMNasdaq : GH conferencesGuardant Health to Participate in the BofA Securities 2022 Healthcare ConferenceGuardant Health, Inc., a leading precision oncology company, today announced it will be participating in the upcoming BofA Securities 2022 Healthcare Conference in Las Vegas, Nevada. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics.RHEA-AIneutral
04/13/22 4:05 PMNasdaq : GH conferencesearningsGuardant Health to Report First Quarter Financial Results on May 5, 2022Guardant Health, Inc., a leading precision oncology company, today announced it will report financial results for the first quarter 2022 after market close on Thursday, May 5, 2022. About Guardant Health Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and...RHEA-AIneutral